4.000USD-4.31%Mkt Cap: 31.02M USDP/E: —Last update: 2026-05-26
Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company. It operates through Pharmaceuticals and Computing Technology segments. The company develops Isomyosamine, a clinical stage small molecule that r…
Industry Peers
Computer Hardware235.82BUSDP/E 54.4
201.54BUSDP/E 55.0
198.53BUSDP/E 35.2
180.66BUSDP/E 31.4
44.02BNOKP/E 38.5
29.78BUSDP/E 163.0
23.58BUSDP/E 162.0
22.41BUSDP/E 123.3
Indicators:|
Key Statistics
Company
Market Cap31.02M USD
Enterprise Value22.18M USD
Revenue (TTM)—
Gross Profit0 USD
Net Income (TTM)-11.63M USD
Revenue/Share—
Last Price4.000 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2
CountryUS
SectorTechnology
IndustryComputer Hardware
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B1.56
EPS (TTM)-8.49
EPS (Forward)—
52W Range
2.5005% of range33.60
52W High33.60 USD
52W Low2.500 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-53.45%
ROA-28.24%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.07M USD
CapEx (TTM)2.01M USD
FCF Margin—
FCF Yield-21.09%
Net Debt-12.97M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.00
Current Ratio3.71
Quick Ratio3.52
Book Value/Sh2.620 USD
Cash/Share1.652 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateSep 2, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.7.85M
Float7.78M
Insiders4.35%
Institutions7.99%
Short Interest
Short Ratio3.7d
Short % Float91.53%
Short % Out.16.95%
Shares Short1.33M
Short (prev mo.)1.45M
Technical
SMA 503.798 (+5.3%)
SMA 2004.498 (-11.1%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)582.73K
Avg Vol (10d)837.30K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—